Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

Tonix's common stock will continue trading on the NASDAQ Capital Market under the symbol "TNXP" and a new ... a candidate for managing fibromyalgia, which has reached the New Drug Application ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline ...

Tonix’s common stock will continue to trade on the NASDAQ Capital Market under the symbol “TNXP” and ... a product candidate for the management of fibromyalgia, for which an NDA was ...

CHATHAM, N.J. - Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), a biopharmaceutical company, has announced a 1-for-100 reverse stock split of its common stock, set to take effect as trading opens ...

Ari Fish is an artist whose work spans multiple disciplines, from painting and sculpture to graphic design and immersive installations. Her passion ...

Tonix's lead product candidate, TNX-102 SL (Tonmya™), is a potential treatment for fibromyalgia, a chronic pain disorder affecting millions. The company's focus on this and other conditions with ...

Dec. 22, 2023 — There does not appear to be any profound differences between so-called exposure-based CBT and traditional CBT in the treatment of fibromyalgia. Both forms of treatment produced a ...

Axsome Therapeutics, Inc.'s' stock surges 30% amid key catalysts. Learn why it's now rated a Buy wih upcoming data opportunities. Click for my AXSM update.